Skip to main content

Advertisement

SpringerLink
Log in

Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis

  • Correspondence
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Samaan MA, de Jong D, Sahami S et al (2016) Incidence and severity of prepouch ileitis: a distinct disease entity or a manifestation of refractory pouchitis? Inflamm Bowel Dis 22:662–668

    Article  PubMed  Google Scholar 

  2. Rottoli M, Vallicelli C, Bigonzi E et al (2018) Prepouch ileitis after ileal pouch-anal anastomosis: patterns of presentation and risk factors for failure of treatment. J Crohn’s Colitis. https://doi.org/10.1093/ecco-jcc/jjx140

    Google Scholar 

  3. Zaghiyan K, Kamiński JP, Barmparas G, Fleshner P (2016) De novo Crohn’s disease after Ileal pouch-anal anastomosis for ulcerative colitis and inflammatory bowel disease unclassified: long-term follow-up of a prospective inflammatory bowel disease registry. Am Surg 82:977–981

    PubMed  Google Scholar 

  4. Bär F, Dietrich NA, Krause Tet al; German IBD Study Group (2018) Vedolizumab in the treatment of chronic, antibiotic dependent or refractory Pouchitis. Aliment Pharmacol Ther. https://doi.org/10.1111/apt.14479

  5. Tran-Minh ML, Allez M, Gornet JM (2017) Successful treatment with ustekinumab for chronic refractory pouchitis. J Crohn’s Colitis 11:1156

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Joint Internal Medicine Practice for Digestive and Metabolic Diseases, Leipzig and Schkeuditz, Nordstr. 21, 04105, Leipzig, Germany

    N. Teich

  2. Internal Medicine Clinic IV, University Clinic, Jena, Germany

    A. Stallmach

  3. Faculty of Medicine, Friedrich-Schiller University, Jena, Germany

    N. Teich & A. Stallmach

Authors
  1. N. Teich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Stallmach
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Teich.

Ethics declarations

Conflict of interest

Niels Teich and Andreas Stallmach received advisory and lecture fees from Janssen.

Ethical approval

The present paper was exempt from approval.

Informed consent

Informed consent was obtained from the individual participant included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teich, N., Stallmach, A. Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis. Tech Coloproctol 22, 251–252 (2018). https://doi.org/10.1007/s10151-018-1754-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-018-1754-9

Search

Navigation